REQUEST A DEMO
Total
USD $0.00
Search more companies

Mbpharm Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: All Other Food Manufacturing | Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Electronic Shopping and Mail-Order Houses | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Mbpharm Sp. z o.o. Profile Updated: July 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Mbpharm Sp. z o.o. is based in Poland, with the head office in Tarnow. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The enterprise was incorporated on January 19, 2018. There was a total negative growth of 90.95% in Mbpharm Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Osiedle Niepodleglosci 2/61
Tarnow; Malopolskie; Postal Code: 33-104

Contact Details: Purchase the Mbpharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Mbpharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Mbpharm Sp. z o.o. report to view the information.
Incorporation Date:
January 19, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Mbpharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-28.57%
Net Profit (Loss) for the Period
-28.57%
Total assets
-90.95%
Total equity
-47.81%
Return on Equity (ROE)
-4.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?